Clinical Trial

A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants

Name: A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants — clinical trial record (NCT07723833)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to measure the pharmacokinetics (PK-how the body processes the study drug) of elecoglipron in healthy participants when taken by mouth as different formulations.

Protocol Amendment History 1 change

critical Recruitment opened 2026-08-04

Trial Details

NCT Number	NCT07723833
Lead Sponsor	AstraZeneca
Conditions	Healthy Participants
Enrollment	152 participants
Start Date	2026-07-27
Primary Completion	2026-11-18 (estimated)
Study Completion	2026-11-18 (estimated)
Updated on ClinicalTrials.gov	2026-08-03